Systemic Delivery of Peptide-Conjugated Antisense Oligonucleotides Leads to Long-Lasting Correction of Myotonic Dystrophy Type I - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2019

Systemic Delivery of Peptide-Conjugated Antisense Oligonucleotides Leads to Long-Lasting Correction of Myotonic Dystrophy Type I

Résumé

Antisense oligonucleotides (ASOs) targeting pathologic RNAs have shown promising therapeutic corrections for myotonic dystrophy type 1 (DM1), abolishing the toxic RNA gain-of-function mechanism caused by nuclear-retained mutant transcripts containing CUG expansions (CUGexp). However, systemic use of ASOs for DM1 remains challenging due to poor drug distribution into skeletal muscle. Here we show that Pip6a-conjugated morpholino phosphorodiamidate oligomer (PMO) dramatically enhanced ASO delivery into striated muscles of HSA-LR mice following systemic administration in comparison to unconjugated PMO. Pip6a-PMOs targeting pathologic expansions reverse the detrimental sequestration of MBNL1 splicing factor by nuclear CUGexp-RNA foci and consequently MBNL1 functional loss that is responsible for splicing defects and muscle dysfunction. Thus, we demonstrate that Pip6a-PMO induces high efficacy, long-lasting correction of DM1-associated phenotypes at both molecular and functional levels, including in patient derived muscle cells with long repeats, strongly supporting the use of advanced peptide-conjugates for systemic corrective therapy in DM1.
Fichier non déposé

Dates et versions

hal-03998386 , version 1 (21-02-2023)

Identifiants

  • HAL Id : hal-03998386 , version 1

Citer

Arnaud F. Klein, Miguel A. Varela, Ludovic Arandel, Ashling Holland, Naira Naouar, et al.. Systemic Delivery of Peptide-Conjugated Antisense Oligonucleotides Leads to Long-Lasting Correction of Myotonic Dystrophy Type I. International Myotonic Dystrophy Consortium Meeting IDMC-12, International Myotonic Dystrophy Consortium, Jun 2019, Gothenburg, Sweden. ⟨hal-03998386⟩
9 Consultations
0 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More